Tech Daily Missouri
SEE OTHER BRANDS

Following science and technology news from Missouri

Tech Daily Missouri: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Daily Missouri.

Press releases published on June 25, 2025

Eyenovia Announces Co-Branded Validator with Kinetiq 

Eyenovia Announces Co-Branded Validator with Kinetiq 

LAGUNA HILLS, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), a pioneer in ophthalmic technologies and the first publicly-listed U.S. company to build a strategic treasury of HYPE, the native token of …

Wearable Devices Advances AI Health Monitoring Platform as U.S. HHS Embraces Wearable Tech

Wearable Devices Advances AI Health Monitoring Platform as U.S. HHS Embraces Wearable Tech

Yokneam Illit, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), a technology growth company specializing in artificial intelligence (“AI”)-powered touchless sensing wearables, …

AgEagle Aerial Systems Announces 100th Drone Sale to South Korea as International Footprint Continues to Expand

AgEagle Aerial Systems Announces 100th Drone Sale to South Korea as International Footprint Continues to Expand

New eBee X units enhance capabilities across agriculture, urban planning, and strategic applications WICHITA, Kan., June 25, 2025 (GLOBE NEWSWIRE) -- AgEagle Aerial Systems Inc. (NYSE: UAVS), a leading provider of advanced drone and aerial imaging …

BTC Miner Surges Amid Bitcoin Boom: Users Earn Up to $8,500 Daily with Zero Effort

BTC Miner Surges Amid Bitcoin Boom: Users Earn Up to $8,500 Daily with Zero Effort

London, UK, June 25, 2025 (GLOBE NEWSWIRE) -- As Bitcoin holds steady above $105,000 and Ethereum remains strong beyond $2,500, global investors are increasingly turning to passive income solutions in the crypto sector. Riding this wave is BTC Miner, a …

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test

Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test

BERKELEY, Calif. and MAINZ, Germany, June 25, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, is pleased to announce that its …

Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus

Evaxion expands R&D pipeline with new vaccine program targeting Group A Streptococcus

Initial computational analysis demonstrated that Evaxion’s AI-Immunology™ platform can identify novel vaccine targets to combat Group A Streptococcus (GAS) New vaccine program is added to Evaxion’s pipeline under the name EVX-B4 Urgent need for preventive …

Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors

Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors

CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Arbor Biotechnologies™, a biotechnology company discovering and developing the next generation of genetic medicines, today announced the appointment of Mikael Dolsten, M.D., Ph.D., to its Board of …

Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B

Assembly Biosciences Reports Positive Topline Results from Phase 1b Clinical Trial of Next-Generation Investigational Capsid Assembly Modulator ABI-4334 in Chronic Hepatitis B

– Favorable safety and tolerability profile, as well as pharmacokinetics supporting once-daily oral dosing, continued to be observed in final 400 mg cohort – – Mean plasma HBV DNA reductions of 3.2 logs IU/mL over 28 days of treatment for 400 mg cohort …

Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab

Corbus Pharmaceuticals Announces First Patient Dosed with its Nectin-4 Targeting ADC CRB-701 in Combination with Pembrolizumab

Combination cohort initiated following successful review of monotherapy cohort Over 100 participants dosed to-date in monotherapy cohort Priority are Head and Neck Squamous Cell Carcinoma (HNSCC) and cervical cancer Data update on schedule for later this …

Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025

Rhythm Pharmaceuticals Announces Three Late-breaking Data Abstracts Accepted for Presentation at ENDO 2025

BOSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that three …

ORYZON to Host Virtual KOL Event on July 9, 2025

ORYZON to Host Virtual KOL Event on July 9, 2025

MADRID and CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a European leader in epigenetics, announced today that it will host a virtual KOL event on …

BigCommerce and Feedonomics Team Up with Perplexity to Help Brands Excel at AI Product Search

BigCommerce and Feedonomics Team Up with Perplexity to Help Brands Excel at AI Product Search

AUSTIN, Texas, June 25, 2025 (GLOBE NEWSWIRE) -- BigCommerce (Nasdaq: BIGC), a leading open SaaS ecommerce platform for B2C and B2B businesses, and Feedonomics, a leading data feed management solution, today announced their customers now have access to …

G2 Recognizes Regula as Identity Verification Leader with 100% Support Satisfaction

G2 Recognizes Regula as Identity Verification Leader with 100% Support Satisfaction

RESTON, Va, June 25, 2025 (GLOBE NEWSWIRE) -- Regula, a global developer of forensic devices and identity verification solutions, has been recognized as a Leader in the G2 Grid® Report for Identity Verification | Summer 2025. Additionally, the company was …

Basecamp Research Announces Malawi Biodiscovery Partnership in Series of New Collaborations Across Three Continents at UK Government Nature Action Event

Basecamp Research Announces Malawi Biodiscovery Partnership in Series of New Collaborations Across Three Continents at UK Government Nature Action Event

Partnerships with Malawi, Hungary, and other new partners will rapidly expand BaseData, the largest biological protein database designed specifically for training generative AI foundation models to improve drug discovery and planetary health. …

BioCardia Announces New United States Patent for Helix Biotherapeutic Delivery System

BioCardia Announces New United States Patent for Helix Biotherapeutic Delivery System

SUNNYVALE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the United States Patent Office …

Report: 1 in 2 Employees Have Excessive Privileged Access—CloudEagle.ai Survey Warns of Escalating Insider Risk due to AI and SaaS Sprawl

Report: 1 in 2 Employees Have Excessive Privileged Access—CloudEagle.ai Survey Warns of Escalating Insider Risk due to AI and SaaS Sprawl

PALO ALTO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- A new report from CloudEagle.ai, the AI-powered SaaS management and governance platform, reveals that 60% of enterprise SaaS and AI applications now operate outside IT's visibility. This surge in “ …

ImmuCell Embarks on CEO Succession Planning Process

ImmuCell Embarks on CEO Succession Planning Process

PORTLAND, Maine, June 25, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …

Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences

Amneal Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR(R) (omalizumab), Developed by Kashiv BioSciences

Amneal holds exclusive U.S. commercialization rights; BLA filing expected in Q4 2025 Poised to be among the first wave of biosimilars in the $3.9 billion U.S. omalizumab market and an important growth driver for Amneal BRIDGEWATER, N.J., June 25, 2025 ( …

Salsify Names Cory McIntyre as Vice President of Global Network, Strengthening Commitment to PXM Innovation

Salsify Names Cory McIntyre as Vice President of Global Network, Strengthening Commitment to PXM Innovation

BOSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Salsify, the leading product experience management (PXM) platform that empowers brands, retailers, and distributors to win on the digital shelf, is thrilled to announce the appointment of Cory McIntyre as Vice …

Nametag Sets New Paradigm in Enterprise Identity Verification with Bring-Your-Own-Storage for PII

Nametag Sets New Paradigm in Enterprise Identity Verification with Bring-Your-Own-Storage for PII

SEATTLE, June 25, 2025 (GLOBE NEWSWIRE) -- Nametag, the leader in workforce identity verification, today announced the general availability of Enterprise Data Custody. Enterprise Data Custody allows organizations to store all personally identifiable …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service